NCT03019029View on ClinicalTrials.gov

Diagnostic Utility of F-18 Florbetapir PET/MR in Peripheral Nerve Amyloidosis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

March 13, 2017

Primary Completion Date

March 22, 2022

Study Completion Date

March 22, 2022

Conditions
Amyloidosis
Interventions
OTHER

18-F Florbetapir PET/MR scan

18-F Florbetapir PET/MR scan, PET/MR on a GE SIGNA PET/MR scanner

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT03019029 - Diagnostic Utility of F-18 Florbetapir PET/MR in Peripheral Nerve Amyloidosis | Biotech Hunter | Biotech Hunter